Annual CFF
$190.15 M
+$73.06 M+62.40%
December 31, 2023
Summary
- As of February 20, 2025, GOSS annual cash flow from financing activities is $190.15 million, with the most recent change of +$73.06 million (+62.40%) on December 31, 2023.
- During the last 3 years, GOSS annual CFF has fallen by -$122.39 million (-39.16%).
- GOSS annual CFF is now -40.87% below its all-time high of $321.58 million, reached on December 31, 2019.
Performance
GOSS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$281.00 K
+$9.49 M+103.05%
September 30, 2024
Summary
- As of February 20, 2025, GOSS quarterly cash flow from financing activities is $281.00 thousand, with the most recent change of +$9.49 million (+103.05%) on September 30, 2024.
- Over the past year, GOSS quarterly CFF has increased by +$3.18 million (+109.68%).
- GOSS quarterly CFF is now -99.91% below its all-time high of $310.83 million, reached on June 30, 2020.
Performance
GOSS Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
-$14.39 M
-$198.22 M-107.83%
September 30, 2024
Summary
- As of February 20, 2025, GOSS TTM cash flow from financing activities is -$14.39 million, with the most recent change of -$198.22 million (-107.83%) on September 30, 2024.
- Over the past year, GOSS TTM CFF has dropped by -$204.54 million (-107.57%).
- GOSS TTM CFF is now -102.63% below its all-time high of $547.10 million, reached on June 30, 2019.
Performance
GOSS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
GOSS Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +62.4% | +109.7% | -107.6% |
| 3 y3 years | -39.2% | -85.3% | -548.7% |
| 5 y5 years | -36.8% | -23.9% | -104.5% |
GOSS Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +5612.1% | -99.9% | +103.0% | -107.6% | at low |
| 5 y | 5-year | -40.9% | +5612.1% | -99.9% | +103.0% | -104.5% | at low |
| alltime | all time | -40.9% | >+9999.0% | -99.9% | +103.0% | -102.6% | at low |
Gossamer Bio Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $281.00 K(-103.0%) | -$14.39 M(-107.8%) |
| Jun 2024 | - | -$9.21 M(+260.6%) | $183.82 M(-3.3%) |
| Mar 2024 | - | -$2.56 M(-12.0%) | $190.13 M(-0.0%) |
| Dec 2023 | $190.15 M(+62.4%) | -$2.90 M(-101.5%) | $190.15 M(-0.0%) |
| Sep 2023 | - | $198.50 M(-6935.3%) | $190.18 M(+71.5%) |
| Jun 2023 | - | -$2.90 M(+14.5%) | $110.91 M(-2.6%) |
| Mar 2023 | - | -$2.54 M(-11.7%) | $113.83 M(-2.8%) |
| Dec 2022 | $117.09 M(+3417.3%) | -$2.87 M(-102.4%) | $117.09 M(-2.7%) |
| Sep 2022 | - | $119.22 M(>+9900.0%) | $120.33 M(+3876.7%) |
| Jun 2022 | - | $21.00 K(-97.1%) | $3.03 M(-7.6%) |
| Mar 2022 | - | $721.00 K(+94.3%) | $3.28 M(-1.6%) |
| Dec 2021 | $3.33 M | $371.00 K(-80.6%) | $3.33 M(+3.8%) |
| Sep 2021 | - | $1.91 M(+605.9%) | $3.21 M(+46.8%) |
| Jun 2021 | - | $271.00 K(-65.0%) | $2.19 M(-99.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $774.00 K(+210.8%) | $312.74 M(+0.1%) |
| Dec 2020 | $312.54 M(-2.8%) | $249.00 K(-72.1%) | $312.54 M(-0.4%) |
| Sep 2020 | - | $891.00 K(-99.7%) | $313.81 M(+0.2%) |
| Jun 2020 | - | $310.83 M(>+9900.0%) | $313.29 M(+917.0%) |
| Mar 2020 | - | $571.00 K(-62.4%) | $30.80 M(-90.4%) |
| Dec 2019 | $321.58 M(+6.9%) | $1.52 M(+311.4%) | $321.58 M(+1.2%) |
| Sep 2019 | - | $369.00 K(-98.7%) | $317.92 M(-41.9%) |
| Jun 2019 | - | $28.35 M(-90.3%) | $547.10 M(+5.2%) |
| Mar 2019 | - | $291.34 M(<-9900.0%) | $520.30 M(+72.9%) |
| Dec 2018 | $300.86 M(+4914.3%) | -$2.14 M(-100.9%) | $300.86 M(-0.7%) |
| Sep 2018 | - | $229.55 M(>+9900.0%) | $303.00 M(+312.5%) |
| Jun 2018 | - | $1.55 M(-97.8%) | $73.45 M(+2.2%) |
| Mar 2018 | - | $71.90 M | $71.90 M |
| Dec 2017 | $6.00 M(>+9900.0%) | - | - |
| Dec 2016 | $40.00 K | - | - |
FAQ
- What is Gossamer Bio annual cash flow from financing activities?
- What is the all time high annual CFF for Gossamer Bio?
- What is Gossamer Bio annual CFF year-on-year change?
- What is Gossamer Bio quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Gossamer Bio?
- What is Gossamer Bio quarterly CFF year-on-year change?
- What is Gossamer Bio TTM cash flow from financing activities?
- What is the all time high TTM CFF for Gossamer Bio?
- What is Gossamer Bio TTM CFF year-on-year change?
What is Gossamer Bio annual cash flow from financing activities?
The current annual CFF of GOSS is $190.15 M
What is the all time high annual CFF for Gossamer Bio?
Gossamer Bio all-time high annual cash flow from financing activities is $321.58 M
What is Gossamer Bio annual CFF year-on-year change?
Over the past year, GOSS annual cash flow from financing activities has changed by +$73.06 M (+62.40%)
What is Gossamer Bio quarterly cash flow from financing activities?
The current quarterly CFF of GOSS is $281.00 K
What is the all time high quarterly CFF for Gossamer Bio?
Gossamer Bio all-time high quarterly cash flow from financing activities is $310.83 M
What is Gossamer Bio quarterly CFF year-on-year change?
Over the past year, GOSS quarterly cash flow from financing activities has changed by +$3.18 M (+109.68%)
What is Gossamer Bio TTM cash flow from financing activities?
The current TTM CFF of GOSS is -$14.39 M
What is the all time high TTM CFF for Gossamer Bio?
Gossamer Bio all-time high TTM cash flow from financing activities is $547.10 M
What is Gossamer Bio TTM CFF year-on-year change?
Over the past year, GOSS TTM cash flow from financing activities has changed by -$204.54 M (-107.57%)